|

Itraconazole Clinical Trials

11 actively recruiting trials across 7 locations

No change since May 2026

Also known as: Onmel, Sporanox, Tolsura

Pipeline

Phase 1: 5Phase 2: 2Phase 1/2: 4

Top Sponsors

  • DualityBio Inc.2
  • VA Office of Research and Development1
  • Pfizer1
  • Nuvalent Inc.1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

Other3 trials

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1
Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors
Phase 1
Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer
Phase 1

Tucson, Arizona2 trials

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 111

Phase 1/2
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Banner-University Medical Center Tucson

Phase 1

Phoenix, Arizona1 trial

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Mayo Clinic Arizona

Phase 1/2

Scottsdale, Arizona1 trial

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

HonorHealth

Phase 1

Cerritos, California1 trial

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Helios Clinical Research

Phase 1/2

Orange, California1 trial

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

University of California Irvine Medical Center

Phase 1/2

Palo Alto, California1 trial

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

VA Palo Alto Health Care System, Palo Alto, CA

Phase 2

Dallas, Texas1 trial

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Dallas VA Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.